FILTER

LATEST INTERVIEWS

Dr. Okan Oncel

GENERAL MANAGER, BILIM ILAC
Bilim Pharmaceuticals is a 100% Turkish drug manufacturer and marketer and ranked 2nd among 300 corporations in the Turkish pharmaceutical industry.

Peter Quarm

DIRECTOR, DUTYLEX
Dutylex is a Ghana-based supplier of lubricants for the West Africa mining industry.

Chris Hodgson

PRESIDENT, ONTARIO MINING ASSOCIATION (OMA)
The Ontario Mining Association (OMA) has launched a social campaign, #ThisIsMining, to promote the benefits of the industry.

Turgut Tokgöz

SECRETARY GENERAL, IEIS
IEIS discusses its initiatives to support Turkey’s ascent as a leading pharmaceutical hub and a competitive player in the biopharma space.

Dr. Yormaz Ismail

MANAGING DIRECTOR, RECORDATI İLAÇ SAN. VE TİC. A.Ş.
Headquartered in Milan and with operations around the globe, Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases.

Jason Smith

GENERAL MANAGER, EPIROC CANADA
The automation revolution is here, and Epiroc is leading the way through its suite of innovative products.

Zeynep Atabay Taşkent & Doğan Taşkent

OWNER & BOARD MEMBER, ATABAY PHARMACEUTICALS AND FINE CHEMICALS
Atabay was founded in Istanbul by Mr. Ö. Kemalettin Atabay in 1939 and today is fully active in producing quality products for human health.

Timothy Beale

PRESIDENT & CEO, REVELO RESOURCES
Chile-based Revelo Resources wants to take its prospect generation business model to the next level.

Stefano Marani

MANAGING DIRECTOR AND CEO, RENERGEN
Renergen discusses the next steps for its Virginia gas field – South Africa’s only onshore petroleum production project.

Samir Gandhi & Kartik Gandhi

MANAGING DIRECTOR AND CEO & DIRECTOR, GANDHI AUTOMATIONS
Gandhi Automations is taking a leading role in introducing the benefits of automation to Indian manufacturers – including the pharma industry.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2024 - Digital Interactive

"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "

PARTNER EVENTS